Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality
C. E. Cunningham, F. S. Vizeacoumar, Y. Zhang, L. Kyrylenko, P. Gao, V. Maranda, H. Dong, J. D. Price, A. Ganapathysamy, R. Hari, C. Denomy, S. Both, K. Wagner, Y. Wu, F. Khan, , M. Empting
The paper identifies synthetic dosage lethality targets for PLK1-overexpressing cancers using genome-wide screens and validates key hits to show their therapeutic potential.
Cell Genomics · Jun 1, 2025Peer-reviewedCancer Biology